维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Maddock HL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide显示文摘	Maddock HL Siedlecka SM Yellon DM	2004	Cardiovasc Drugs Ther2004，18，2：	1
2	Adenosine a(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury显示文摘	Maddock HL Mocanu MM Yellon DM		0，，04：	1
3	Glimepiride,a novel sulfonylurea,does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide显示文摘	Mocanu MM Maddock HL Baxter GF	2001	Circulation2001，103，：	1
4	Myocardial protection from either ischemie preconditioning or Nieorandil is not blocked by gliclazide 显示文摘	Maddock HL Siedlecka SM Yellon DM	2004	Cardiovasc Drugs Ther2004，18，：	1
5	Inh ibiting mitoehondrial permeability transition pore opening:a new paradigm for myocardial preconditioning显示文摘	Hausenloy DJ Maddock HL Baxter GF	2002	Cardiovase Res2002，55，：	1
6	Ipratropium bromide-mediated myocardial injury in in vitro models of myocardial ischaemiaJ reperfilsion显示文摘	Harvey KL Hussain A Maddock HL	2014	Toxicological Sciences2014，138，2：	1
7	Glimepiride,a novel sulfonylurea,dose not abolish myocardial protection afforded by either ischemic preconditioning on diazoxide 显示文摘	Mocanu MM Maddock HL Baxter GF	2001	Circulation2001，103，：	1
8	Glimepiride, anovel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide 显示文摘	Mocanu MM Maddock HL Baxter GF	2001	Circulation2001，103，：	1
9	Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning显示文摘	Hausenloy DJ Maddock HL Baxter GF	2002	Cardiovasc Res2002，55，3：	1
10	The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart显示文摘	Bell RM Maddock HL Yellon DM	2003	Cardiovasc Res2003，57，：	1
11	Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning显示文摘	Hausenloy D] Maddock HL Baxter GF e al	2002	Cardiovasc Res2002，55，3：	1
12	Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide显示文摘	Maddock HL Siedlecka SM Yellon DM	2004	Cardiovasc Drugs Ther2004，18，2：	1
13	Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning 显示文摘	Hausenloy DJ Maddock HL Baxter GF	2002	Cardiovasc Res2002，55，3：	1
14	Glimepiride,a novel sulfonylurea,does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide显示文摘	Mocanu MM Maddock HL Baxter GF	2001	Circulation2001，103，：	1
15	Adenosine A(3) recep- tor activation protects the myocardiuro from reperfusion/reoxygen- ation injury显示文摘	Maddock HL Mocanu MM Yellon DM	2002	Am J Physiol Heart Circ Physiol2002，283，4：	1
16	Inhibiting mitochondrial permeability transition pore opening:a new paradigm for myocardial preconditioning显示文摘	Hausenloy DJ Maddock HL Baxter GF	2002	Cardiovasc Res2002，55，3：	1
17	Inhibiting mitochondrial permeability transition pore opening:a new paradigm for myacardial preconditioning?显示文摘	Maddock HL Baxter GF	2002	Cardiovasc Res2002，55，3：	1
18	Inhibiting mitochondrial permeability transition pore opening a new paradigm for myocardial preconditioning 显示文摘	Hausenloy DJ Maddock HL Baxter GF	2002	Cardiovasc Res2002，55，3：	1
19	The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart显示文摘	Bell RM Maddock HL Yellon DM	2003	Cardiovasc Res2003，57，：	1
20	Inhibiting mitochondrial permeability transition pore opening: A new paradigm for myocardial preconditioning显示文摘	Hausenloy DJ Maddock HL Baxter GF	2002	Cardioasc Res2002，55，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示